UK briefed on COVID-19 situation in India to review 'red list' travel ban
"It's an Oxford/AstraZeneca vaccine being manufactured under a transfer of technology in India so there can't be any difference in product - between that produced at the Serum Institute of India (SII) or anywhere else," said Shringla.